Isolation rates of Brucella melitensis in an endemic area and implications for laboratory safety

被引:14
作者
Shemesh, A. A. [1 ]
Yagupsky, P. [1 ]
机构
[1] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Clin Microbiol Lab, IL-84101 Beer Sheva, Israel
关键词
Blood Culture; Brucellosis; Laboratory Personnel; Clinical Microbiology Laboratory; Human Brucellosis;
D O I
10.1007/s10096-011-1325-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A retrospective study was conducted to assess the potential threat posed by processing blood cultures to clinical microbiology laboratory personnel working in an area endemic for Brucella melitensis in southern Israel. The computerized laboratory records for the 2002-2009 period were reviewed, and the proportion of aerobic vials from which Brucella organisms were isolated out of the total number of positive aerobic blood culture vials was determined. During the 8-year period, B. melitensis was isolated in 514 of 20,620 (2.5%) positive vials. Isolation rate increased at the end of the period reaching a peak of 5.3% in 2008. Between April 2008 and September 2009, the proportion of aerobic blood cultures from which B. melitensis was isolated was even higher than that positive for pneumococci (4.3% and 2.6%, respectively, P < 0.001). Although it has been recommended that processing of Brucella cultures should be confined to a Class II biologic safety cabinet, by the time the organism is identified, extensive manipulation of culture media has already been performed and inadvertent exposure of laboratory personnel may have already occurred. To reduce the risk of transmission, all positive blood culture vials in endemic areas should be processed in a safety cabinet.
引用
收藏
页码:441 / 443
页数:3
相关论文
共 11 条
[1]   ISOLATION, IDENTIFICATION, AND CHARACTERIZATION IN ISRAEL OF BRUCELLA-MELITENSIS BIOVAR-1 ATYPICAL STRAINS SUSCEPTIBLE TO DYES AND PENICILLIN, INDICATING THE EVOLUTION OF A NEW VARIANT [J].
BANAI, M ;
MAYER, I ;
COHEN, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (05) :1057-1059
[2]  
Centers for Disease Control and National Institutes of Health, 1988, NIH PUBL
[3]   Analysis of risk factors for laboratory-acquired brucella infections [J].
Ergönül, Ö ;
Çelikbas, A ;
Tezeren, D ;
Güvener, E ;
Dokuzoguz, B .
JOURNAL OF HOSPITAL INFECTION, 2004, 56 (03) :223-227
[4]   Laboratory-acquired brucellosis [J].
Noviello, S ;
Gello, R ;
Kelly, M ;
Limberger, RJ ;
DeAngelis, K ;
Cain, L ;
Wallace, B ;
Dumas, N .
EMERGING INFECTIOUS DISEASES, 2004, 10 (10) :1848-1850
[5]   The new global map of human brucellosis [J].
Pappas, G ;
Papadimitriou, P ;
Akritidis, N ;
Christou, L ;
Tsianos, EV .
LANCET INFECTIOUS DISEASES, 2006, 6 (02) :91-99
[6]  
PIKE RM, 1978, ARCH PATHOL LAB MED, V102, P333
[7]   COMPARING 2 PROPORTIONS FROM THE SAME SURVEY [J].
WILD, CJ ;
SEBER, GAF .
AMERICAN STATISTICIAN, 1993, 47 (03) :178-181
[8]   Laboratory exposures to brucellae and implications for bioterrorism [J].
Yagupsky, P ;
Baron, EJ .
EMERGING INFECTIOUS DISEASES, 2005, 11 (08) :1180-1185
[9]   Comparison of BACTEC 9240 Peds Plus medium and Isolator 1.5 Microbial Tube for detection of Brucella melitiensis from blood cultures [J].
Yagupsky, P ;
Peled, N ;
Press, J ;
Abramson, O ;
AbuRashid, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) :1382-1384
[10]   Detection of Brucellae in blood cultures [J].
Yagupsky, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (11) :3437-3442